✨ Free AI Report
BostonGene: Key Facts, Business Model & Financial Analysis Read the overview below or get the full interactive report with Cyborg Score, analyst debate audio & saved-company playlists — free, no credit card.
Get Free Report →
Home Company Research BostonGene
Company Research

BostonGene: Business Overview, Financials & Competitive Analysis

BostonGene scores 9/10 on the AskCyborg Cyborg Score (Exceptional). AI-powered precision oncology platform with unmatched institutional credibility poised to capture significant value in personalized cancer medicine. BostonGene demonstrates exceptional market positioning as a unicorn biotech with comprehensive AI-driven precision oncology capabilities, elite academic and pharma partnerships, multiple industry awards in 2025, and proven ability to accelerate drug development and patient.

What is BostonGene's industry? BostonGene (bostongene.com) operates in Oncology Drugs. AskCyborg classifies BostonGene under Oncology Drugs in its company registry.

BostonGene redefines cancer patient care and drug development through the integration of omnimodal data and AI. Built and validated through an extensive real-world clinical testing network, BostonGene's Foundation Mod...

9/ 10Exceptional

Cyborg Score thesis

AI-powered precision oncology platform with unmatched institutional credibility poised to capture significant value in...

Read the full analyst-debate transcript →
Industry Oncology Drugs
3 named competitors
3 recent developments
11 analyst dimensions
Synthesized from analyst-debate stress-testing across 11 dimensions and hundreds of data points. Methodology →
Cyborg Score recalibrated: September 28, 2026
AI-Verified Research
30+ Page Report

Get the Latest BostonGene Report

Up-to-date AI-powered research, analyst debate audio & saved-company playlists

Get Current Report Free
✓ No credit card required
or get it by email

Analyst-debate audio for BostonGene

AskCyborg analysts argue the bull and bear cases for BostonGene across 11 stress-tested dimensions. Listen on your commute -- faster than reading the 30-page report.

Play the free intro →
Free intro · Pro unlocks the full analyst debate
What's in This Report
BostonGene OverviewStrategic ProfileCompetitive LandscapeIndustry ContextKey facts
Get Interactive Report Freeor start reading below

BostonGene Overview

Pro stress-test →

BostonGene redefines cancer patient care and drug development through the integration of omnimodal data and AI. Built and validated through an extensive real-world clinical testing network, BostonGene's Foundation Model of cancer and the immune system integrates genomic, transcriptomic, and immune data with clinical outcomes to generate biologically grounded, actionable insights.

Strategic Profile

Pro stress-test →

BostonGene has established unrivaled credibility across oncology and immunology through a collaborative ecosystem of deep academic partnerships with MD Anderson Cancer Center, Memorial Sloan Kettering, Dana Farber Cancer Institute, the Mayo Clinic, and other leading cancer institutions across the globe. These are complemented by strategic business partnerships with AstraZeneca, Johnson & Johnson, Takeda, Ottimo Pharma, and other global pharma and biotech leaders. The company's industry-leading innovation has been recognized with awards such as Frost & Sullivan's 2025 Global Technology Innovation Leadership Award in AI-driven Precision Oncology Solutions, as well as BioTech Breakthrough's 2025 Overall Immunology Company of the Year and 2025 AI-based Drug Discovery Solution of the Year.

Competitive Landscape

Pro stress-test →

Strata Oncology develops biomarkers for cancer treatment, offering tools that analyze tumor biology to predict patient response to therapies, serving the biopharmaceutical sector and based in Ann Arbor, Michigan since 2015. SimBioSys provides visualization and diagnostic technology aimed at addressing clinical questions in cancer care with cloud-based tools and AI solutions, based in Chicago, Illinois since 2018. BostonGene differentiates through its comprehensive Foundation Model, elite institutional networks, and multi-omics integration across genomics, transcriptomics, and immune profiling.

Industry Context

BostonGene operates in Oncology Drugs.

Key facts

Founded: 2015 · Headquarters: Waltham, Massachusetts, US · Employees: N/A · Revenue: N/A · Market cap: N/A

What the analysts stress-tested

The top findings that survived the multi-agent debate for BostonGene.

  • Recognized as 2025 Overall Immunology Company of the Year and 2025 AI-based Drug Discovery Solution of the Year by BioTech Breakthrough
  • Partnerships span leading cancer centers (MD Anderson, MSK, Dana Farber) and major pharma (AstraZeneca, Johnson & Johnson, Takeda)
+2 more stress-tested counter-arguments unlock with Pro. Read the full analyst debate →

Recent developments

Material events tracked by the AskCyborg corpus.

  • April 2026Showcased AI foundation model at AACR26 with integrated genomic, transcriptomic, and spatial insights for drug discovery and clinical trials
  • February 2025Won three 2024 Clinical Trials Arena Excellence Awards in Innovation, Product Launches, and Marketing categories
  • +1 moreTrack every material event for BostonGene as it happens. Explore monitoring →
Get alerted when BostonGene has a new material development →

Named competitors

Pulled from the analyst-debate framework. Click any competitor to see their Cyborg Score.

Strata OncologyBiomarker analysis and tumor biology prediction for cancer treatment→SimBioSysAI-powered visualization and precision medicine diagnostics→TempusAI-driven molecular insights for cancer treatment→

Compare BostonGene with another company

Pick any company in the AskCyborg corpus to see side-by-side Cyborg Scores and insights.

vs
Side-by-side opens in your AskCyborg account

Industry context

BostonGene operates in Oncology Drugs. See how the rest of the sector scores on the Cyborg framework.

Browse Oncology Drugs research →
NEW · MCP server

Ask your AI assistant about BostonGene

Install the free AskCyborg MCP server in Claude, Cursor, Cline, Continue, or Windsurf and ask any of these in-line:

“Compare BostonGene and its top competitor on Cyborg Score”
“What did BostonGene do this quarter?”
“Is BostonGene a defensible business in 5 years?”
Install the MCP server (10 sec) →
Free, anonymous, no API key required

How AskCyborg builds confidence

⚔

Analyst debate, not single-author opinion

Every report is stress-tested by a panel of AI analysts arguing across 11 dimensions. The output is the part of the case that survived pushback.

📊

Recalibrated weekly

The Cyborg Score is recomputed weekly against fresh data. Recent material developments are continuously tracked and surfaced.

🔗

Methodology open at /methodology

The framework, dimensions, and band breakdowns are documented. The same company gets the same score from any analyst running the framework.

🔒

Free tier is free

No credit card to read the research. Pro adds saved-company audio playlists, monitoring, audio briefings on demand, and PDF export for $39/mo annual.

Sources: public filings, regulatory data, news flow, and proprietary analyst signals. Read the methodology →

Frequently asked questions

What does BostonGene do?+
BostonGene redefines cancer patient care and drug development through the integration of omnimodal data and AI. Built and validated through an extensive real-world clinical testing network, BostonGene's Foundation Mod...
What is BostonGene's Cyborg Score?+
BostonGene has a Cyborg Score of 9/10 (Exceptional). The score synthesizes business model, financials, leadership, competitive position, technology, marketing, and ESG dimensions across hundreds of data points.
Who are BostonGene's main competitors?+
Named competitors include Strata Oncology, SimBioSys, Tempus. The full competitive landscape is in the AskCyborg report.
How can I get the full BostonGene research report?+
Get the report plus analyst-debate audio at askcyborg.com -- no credit card required for preview access. Pro adds saved-company audio playlists and monitoring.
How current is the BostonGene research?+
The Cyborg Score is recalibrated weekly. Recent developments are tracked continuously and surfaced in every report.

Track BostonGene over time

Pro members get saved-company audio playlists, Cyborg Score recalibrations, and monitoring for material events across the AskCyborg corpus.

See Pro features
From $39/mo annual

Top-scored companies on AskCyborg

The strongest performers across the analyst-debate framework.

9Advantest Corporation9Anthropic9Apple Inc.9Applied Materials, Inc.9Arista Networks9Aritzia Inc.9ASML Holding N.V.9BAE Systems plc9Barrick Mining Corporation9Berkshire Hathaway Inc.